News & Events
GLW Trauma Announces FDA 510(K) Clearance for the Artemis Proximal Femoral Nail System
NEW LONG NAIL TO STRENGTHEN THE ARTEMIS SYSTEM AND STREAMLINE WORKFLOWS ENGLEWOOD CLIFFS, NJ, USA, October 31, 2022 / – Altior Trauma a GLW, Inc. company, (“GLW Trauma”), a medical device company focused on a paradigm shift in the surgical treatment of trochanteric hip fractures, announced today an additional U.S. Food and Drug Administration (FDA) 510(k) clearance … Continued
Carbon22 Receives FDA 510(k) Clearance for Apollo™ Ankle Fracture Plating System
Englewood Cliffs, NJ., — Carbon22™, a GLW, Inc. medical technology company with a focus on the foot and ankle orthopedic market, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its upcoming Apollo Ankle Fracture Plating System, a novel portfolio of see-through, “ortholucent” bone plates and screws used … Continued
Solvay and Carbon22™ partner on Creed™ Cannulated Screws for orthopedics
Alpharetta, Ga., — Solvay’s Zeniva® polyetheretherketone (PEEK) resin was chosen by Carbon22™, a GLW, Inc. company, for its new Creed™ Cannulated Screw System for foot and ankle surgery. This advanced new screw system recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA). To create the new system’s ortholucent, plastic-metal hybrid composite, Solvay’s implant-grade radiolucent Zeniva® PEEK resin … Continued
GLW Trauma Announces FDA 510(K) Clearance for the Artemis Proximal Femoral Nail System
A FOURTH-GENERATION HIP FRACTURE NAIL MANUFACTURED USING A REVOLUTIONARY PROCESS ENGLEWOOD CLIFFS, NJ, USA, February 22, 2021 / – Altior Trauma a GLW, Inc. company, (“GLW Trauma”) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Artemis Proximal Femoral Nail System (the “Artemis System”), a hip fracture nail. The … Continued
Carbon22 Receives FDA 510(k) Clearance for the Creed™ Cannulated Screw System
ENGLEWOOD CLIFFS, NJ, USA, December 17, 2020 — Carbon22™, a GLW, Inc. company, announced today that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) to market the Creed™ Cannulated Screw System, a portfolio of unique, see-through “ortholucent” bone screws used for foot and ankle surgery. The Creed System was developed … Continued
Carbon22 Receives FDA 510(k) Clearance for FusionFrame™ Ring Lock System
Carbon22 Consortium designed circular external fixator can treat complex foot and ankle deformities as well as provide a static frame for various indications. ENGLEWOOD CLIFFS, NJ, USA, September 29, 2020 — Carbon22, a GLW, Inc. company, (“Carbon22”) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new … Continued